What comes after perioperative immunotherapy? Rethinking first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)

Oral Oncology Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles